Co-Founder & CEO, Hexagon Bio
Maureen is a co-founder and CEO of Hexagon Bio. Previously she was the director of the Genomes to Natural Products program at the Stanford Technology Genome Center, where she led technology development for discovery of drug-like metabolites using bioinformatics and synthetic biology. Maureen’s interdisciplinary background spans biology, genomics, and computer science, representing the interdisciplinary nature of Hexagon as a company.